Ethypharm
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
9
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 16, 2027The maintenance fee for Granules of an active substance with double taste-masking technique, method for the production thereof, and orodispersible tablets containing same (US 11,872,306) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,126 | Orally-dispersible multilayer tablet In force · From the USPTO record | In force | From the USPTO record | |
| US 7,846,460 | Composition comprising a mixture of active principles, and method of preparation In force · From the USPTO record | In force | From the USPTO record | |
| US 8,465,776 | Granule and orally disintegrating tablet comprising oxycodone In force · From the USPTO record | In force | From the USPTO record | |
| US 8,865,219 | Orodispersible tablets of bitter active principles In force · From the USPTO record | In force | From the USPTO record | |
| US 8,663,682 | Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles In force · From the USPTO record | In force | From the USPTO record | |
| US 9,492,397 | Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules In force · From the USPTO record | In force | From the USPTO record | |
| US 8,709,479 | Sublingual coated tablet of fentanyl In force · From the USPTO record | In force | From the USPTO record | |
| US 9,629,800 | Gastroretentive formulations and manufacturing process thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,111,869 | Reduction of opioid blood fluctuations In force · From the USPTO record | In force | From the USPTO record | |
| US 8,815,944 | Pharmaceutical composition with gelling properties containing a tyrosine derivative In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 18: 9 lapsed for an unpaid fee · 38 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 23 no status recorded